Thrombophilia panel - 4 mutations
Definition
The Factor V Leiden component of these panels is covered in the glossary as a separate term. The panel-specific Factor II (Prothrombin) G20210A variant increases the circulating amount of prothrombin protein, making blood more prone to clotting; heterozygous carriers have a several-fold increased risk of thrombosis, but most carriers never develop thrombosis. The MTHFR C677T/A1298C variants that are frequently added to such panels have not been shown by current evidence to increase the risk of venous thromboembolism; ACMG has stated that these variants should not be ordered as part of routine thrombophilia evaluation.
Gene/region examined
Factor II G20210A, Factor V Leiden, MTHFR A1298C, MTHFR C677T
Method
Sequence analysis
Accepted sample types
EDTA blood
Inheritance
Prothrombin thrombophilia is inherited in an autosomal dominant manner; carrying a single mutant copy is sufficient, and the chance of transmission from a heterozygous parent to a child is 50 percent.